Results 171 to 180 of about 9,592 (241)

Challenges in the Diagnosis of Autoimmune Hepatitis in Patients With Chronic Viral Hepatitis C: A Case Series and Review of the Literature. [PDF]

Cureus
Malakar S, Kumar S, Jangra R, Agarwal M, Parwar A, Kohli KP, Mishra S, Bhardwaj A, Kumar A, Singh A, Yadav DK, Tiwari A, Gandhi A, Shukla G, Rungta S.   +14 more
europepmc   +1 more source

901d Daclatasvir Plus Sofosbuvir for Treatment of HCV Genotypes 1-4 in HIV-HCV Coinfection: The ALLY-2 Study

, 2015
David Wyles, Peter Ruane, Mark Sulkowski, Douglas T. Dieterich, Anne F. Luetkemeyer, Timothy R. Morgan, Kenneth E. Sherman, Zhaohui Liu, Stephanie Noviello, Peter Ackerman   +9 more
openalex   +1 more source

Budget impact analysis of glecaprevir/pibrentasvir treatment for hepatitis C in Iran: a modelling study. [PDF]

BMJ Open
Jafari M, Mehdizadeh P, Keshavarz K, Teymourzadeh E, Abyazi MA, Gholamreza Shirazi P.   +5 more
europepmc   +1 more source

Forced Oxidative Degradation of Anti-Hepatitis C Drugs Sofosbuvir and Daclatasvir: Characterization and Quantification [PDF]

Sabrein H. Mohamed, Rasha M.K. Mohamed, Aida L. El‐Ansary, Ahmed I. Mahmoud, Tamer H. A. Hasanin   +4 more
openalex   +1 more source

Evaluation of the Strategy and Efficacy of Treatment of Chronic Viral Hepatitis C with the Sofosbuvir/Daclatasvir Combination in a Resource-Limited Country

Mayanna Habkréo, Ali Mahamat Moussa, Adama Ahmed Ngare, Abdraman Kossou, Tahir Mahamat Saleh, Mairé Dehainsala, Mahamat Ali Hachim, Mahamat Ali Bolti, Oumaima Djarma, Joseph Mad-Toïngué   +9 more
openalex   +2 more sources

Enhanced information cross-attention fusion for drug-target binding affinity prediction. [PDF]

PeerJ Comput Sci
Fei A, Wang Y, Ruan T, Zhang Y, Yao M, Wang L.   +5 more
europepmc   +1 more source

<p>Prevalence and predictors of occult hepatitis C virus infection among Egyptian patients who achieved sustained virologic response to sofosbuvir/daclatasvir therapy: a multi-center study</p>

, 2019
Mohamed A. Mekky, Hani I Sayed, Mohamed Abdelmalek, Medhat A. Saleh, Osman A. Osman, Heba Ahmed Osman, Khairy H. Morsy, ‏Helal F. Hetta   +7 more
openalex   +2 more sources

Hepatitis C Direct-Acting Antivirals in the Immunosuppressed Host: Mechanisms, Interactions, and Clinical Outcomes. [PDF]

Viruses
AlKaabi H, AlSinani S, El-Kassas M, Alswat KA, AlNaamani KM.   +4 more
europepmc   +1 more source

Prevalence of resistance-associated substitutions (RAS) in hepatitis C virus in the Former Soviet Union countries. [PDF]

BMJ Open Gastroenterol
Mustafa A, Davlidova S, Abidi SH, Begimbetova D, Heimer R, Vermund SH, Ali S.   +6 more
europepmc   +1 more source

Evaluation of Resistance-Associated Substitutions in NS5A Using Direct Sequence and Cycleave Method and Treatment Outcome with Daclatasvir and Asunaprevir for Chronic Hepatitis C Genotype 1

, 2016
Tatsuya Ide, Yuichiro Eguchi, Masaru Harada, Kunihide Ishii, Masaru Morita, Yasuyo Morita, Gen Sugiyama, Hirofumi Fukushima, Yoichi Yano, Kazunori Noguchi, Hiroki Nakamura, Junjiro Hisatomi, Hiroto Kumemura, Miki Shirachi, Shinji Iwane, Michiaki Okada, Yuichi Honma, Teruko Arinaga‐Hino, Ichiro Miyajima, Kei Ogata, Reiichiro Kuwahara, Keisuke Amano, Toshihiro Kawaguchi, Ryoko Kuromatsu, Takuji Torimura   +24 more
openalex   +2 more sources